MITA asks CMS to improve radiopharmaceutical coverage
AuntMinnie
SEPTEMBER 13, 2023
The Medical Imaging and Technology Alliance (MITA) has raised concerns ove. Senate MITA hails radiopharmaceutical legislation
Gallium Radiopharmaceuticals in Medical Imaging
Open Medscience
NOVEMBER 17, 2023
Gallium, predicted by Mendeleev, now revolutionises medical diagnostics with its unique radiopharmaceutical applications in oncology. The post Gallium Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.
Join 5,000
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
IMV: PET scan volumes continue to grow
AuntMinnie
MARCH 7, 2024
In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging.
PET Scan 
290
290 
Technetium-99m Radiopharmaceuticals in Advanced Medical Imaging
Open Medscience
NOVEMBER 12, 2023
Technetium-99m, discovered in 1937, transformed medical imaging with its versatile and safe diagnostic applications. The post Technetium-99m Radiopharmaceuticals in Advanced Medical Imaging appeared first on Open Medscience.
MITA members find new home for imaging equipment advocacy efforts
AuntMinnie
DECEMBER 11, 2023
Key corporate members and staff from the Medical Imaging Technology Alliance (MITA) are launching a new medical imaging technology division at medical technology trade association Advanced Medical Technology Association (AdvaMed).
Imaging 278
278 
Generative AI, radiologist shortages feature in 2024 Minnies
AuntMinnie
NOVEMBER 12, 2024
Stewart was appointed to her current teaching role in August 2022 but says achieving her PhD in health informatics and working later at the Society for Imaging Informatics in Medicine (SIIM) has brought her career full circle, so far. from Ukraine.
Radiologist 360
360 
The Transformative Impact of Radiopharmaceuticals in Medical Imaging
Open Medscience
JANUARY 12, 2024
Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.
Radionuclides from Discovery to Modern Medical Imaging
Open Medscience
NOVEMBER 10, 2023
From Becquerel's discovery in 1896 to modern medical applications, radionuclides have revolutionised our approach to science, medicine, and industry. The post Radionuclides from Discovery to Modern Medical Imaging appeared first on Open Medscience.
Medical Imaging 105
105 
FCH-PET/CT superior to MIBI-SPECT/CT for guiding parathyroid surgery
AuntMinnie
JUNE 20, 2024
These findings suggest that first-line FCH-PET/CT can replace MIBI-SPECT/CT for imaging-guided surgery in patients with PHPT,” the group wrote. Medical imaging is used to localize parathyroid adenomas in patients with PHPT, a condition often diagnosed based on high calcium levels. The full study is available here.
Meet the Minnies 2024 finalists
AuntMinnie
OCTOBER 25, 2024
She currently serves as chair of the department of medical imaging and radiation sciences in the College of Health Professions at TJU and directs the radiography and invasive cardiovascular technology programs. She continued working at the hospital for 12 years while growing in her role as an educator.
Nuclear Medicine 358
358 
MITA chides CMS on beta-amyloid PET decision
AuntMinnie
JUNE 7, 2023
The Medical Imaging and Technology Alliance (MITA) has expressed concern ove. discussion
Medical Device 130
130 
Radiopharmaceuticals used in nuclear medicine
Open Medscience
JULY 28, 2019
Radiopharmaceuticals are used in nuclear medicine for the application of medical imaging and therapy. The post Radiopharmaceuticals used in nuclear medicine appeared first on Open Medscience.
SNMMI: AI PET/CT tool accurately segments tumors for multiple cancers
AuntMinnie
JUNE 10, 2024
“The approach may also assist in the early management of patients with advanced, end-stage disease by identifying appropriate treatment regimens and predicting response to therapies, such as radiopharmaceutical therapy.” Automatic cancer detection and characterization can make way for early treatment and better patient outcomes.
Nuclear Medicine 257
257 
UCSF, GE HealthCare Launch Joint Research Program to Drive Innovation
Imaging Technology
JANUARY 27, 2025
Building an ImagingService Line of the Future UCSF and GE HealthCare aim to improve medical imaging services by developing more automated imaging methods, such as patient-specific magnetic resonance imaging (MRI) techniques that could adapt to patient needs in real time. tim.hodson Mon, 01/27/2025 - 10:11 Jan.
Healthcare 59
59 
What Does It Take to Become a Radiologist?
TRA Medical Imaging
JANUARY 17, 2025
Medical School: They then complete four years of medical school, mastering the fundamentals of anatomy, pathology, pharmacology, and patient care. This rigorous training covers all imaging modalities, from X-rays to advanced techniques like MRI and PET/CT scans. TRA Medical Imaging: Where Expertise Meets CompassionClose to Home.
Radiologist 52
52 
MITA praises FDA for Leqembi approval
AuntMinnie
JULY 10, 2023
The Medical Imaging and Technology Alliance (MITA) is praising the U.S. discussion
Medical Device 100
100 
MITA urges 'one stability, one facility' with PET drug inspections
AuntMinnie
OCTOBER 4, 2024
The Medical Imaging and Technology Alliance (MITA) with the Coalition of PET Drug Manufacturers is urging the U.S. Food and Drug Administration (FDA) to maintain its “one stability, one facility” approach to inspections for PET drugs. the letter continued.
NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies
Imaging Technology
APRIL 13, 2023
He has more than 22 years of operational and commercial expertise in radioisotopes and radiopharmaceuticals. actinium-225 (Ac-225), and drive business development initiatives for NorthStar’s Radiopharmaceutical CDMO/CMO business units. Ac-225 and Cu-67 using environmentally preferable technologies.
Interview: Helen Blanco talks about innovation in oncology space
Keosys Medical Imaging
AUGUST 26, 2024
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space.
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production
Imaging Technology
JULY 25, 2024
BWXT Medical will collaborate closely with NorthStar, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, to streamline production processes, enhance safety protocols and innovate new methods of isotope generation.
Medical 105
105 
NorthStar Medical Radioisotopes Expands Management Team with Appointment of Jean-Noel David, MBA, MS, as Vice President, Operations
Imaging Technology
APRIL 24, 2023
milla1cf Mon, 04/24/2023 - 14:10 April 24, 2023 — - NorthStar Medical Radioisotopes , LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the appointment of Jean-Noel David , MBA, MS, as Vice President, Operations.
Medical 98
98 
First Participant Treated Using NorthStar Medical Radioisotopes’ Electron Accelerator-produced Copper-67 (Cu-67) in Clarity Pharmaceuticals’ Phase I/IIa Theranostic Clinical Trial Investigating Cu-67 SARTATE for Treatment of Neuroblastoma
Imaging Technology
AUGUST 29, 2023
Alan Taylor , stated, “Large-scale manufacture of therapeutic Cu-67 from highly efficient, environmentally preferable electron accelerators is critical to overcome the widespread supply issues in the radiopharmaceutical industry, due to a heavy reliance on a small number of antiquated nuclear reactors.
NorthStar Medical Technologies, LLC Appoints Frank Scholz, Ph.D., as President and Chief Executive Officer
Imaging Technology
JUNE 19, 2023
milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D.,
Medical 98
98 
NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones
Imaging Technology
APRIL 3, 2023
Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.
Medical 98
98 
SNMMI taps Urbain as president-elect
AuntMinnie
JUNE 9, 2024
As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible," Urbain said in an SNMMI announcement. Jean-Luc Urbain, MD, PhD. “As
Nuclear Medicine 100
100 
Interview: Focus on the Scandinavian pharmaceutical market
Keosys Medical Imaging
AUGUST 26, 2024
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. Here is another excerpt from our conversation.
TTG Imaging Solutions Announces Acquisition by Sentinel Capital Partners
TTG Imaging Solutions
DECEMBER 26, 2021
Mastarone continued, “It was our goal to find a partner who shared our vision of TTG within the broader medical imaging industry. We aim to provide the highest quality equipment and service and to deliver value to our customers through turnkey staffing and radiopharmaceutical solutions in our end-to-end model.
Imaging 52
52 
TTG Imaging Solutions Acquires Digirad Health from Star Equity Holdings
TTG Imaging Solutions
MAY 5, 2023
Through a nationwide network of field service engineers, TTG offers equipment, maintenance and repair services, clinical staffing, and radiopharmaceutical products. TTG is ISO 9001:2015 and ISO 13485:2016 certified in sales, repair, refurbishment, installation, parts, and servicing of medical imaging devices.
Imaging 52
52 
TTG Imaging Solutions, LLC Announces Executive Leadership Changes
TTG Imaging Solutions
NOVEMBER 1, 2021
PITTSBURGH, PA (November 1, 2021) – TTG Imaging Solutions, LLC (TTG) announced today executive leadership changes that will drive the company’s next phase of growth following its 9th acquisition in 2 years of Medical Imaging Technologies, an Akron, Ohio based nuclear medicine equipment and service organization.
Illuminating the Future: Recent Breakthroughs in Nuclear Medicine Advancements (Maharashtra, Raigarh, Sangli, Satara, Sindhudurg, Solapur, Thane, Wardha, Washim, Yavatmal)
Future Teleradiology
NOVEMBER 27, 2023
This blog post sheds light on recent breakthroughs in nuclear medicine, illuminating the innovative advancements that are shaping the future of medical imaging and treatment. Discuss how these advancements enhance imaging capabilities, providing clearer insights into physiological processes.
Visit TTG Imaging Solutions at SNMMI 2022 Annual Meeting
TTG Imaging Solutions
MAY 26, 2022
ISO 9001:2015 and ISO 13485:2016 certified in sales, repair, refurbishment, installation, parts, and servicing of medical imaging devices. For the latest updates on TTG Imaging Solutions, connect with us on LinkedIn , Twitter , and Facebook. For more information, visit www.ttgimagingsolutions.com.
Breaking Ground: Exploring the Latest Innovations in the Field of Nuclear Medicine (Madhya Pradesh, Bhopal, Raisen, Rajgarh, Sehore, Vidisha, Morena, Sheopur, Bhind, Gwalior, Ashoknagar)
Future Teleradiology
NOVEMBER 21, 2023
This blog explores the latest innovations in nuclear medicine, shedding light on cutting-edge technologies and breakthroughs that are reshaping the landscape of medical imaging and treatment. Highlight how this field merges principles of physics with medical applications for both diagnostic and therapeutic purposes.
Blue Earth Diagnostics Highlights Presentations on POSLUMA (Flotufolastat F 18) in Prostate Cancer at Upcoming ASTRO Annual Meeting
Imaging Technology
SEPTEMBER 27, 2023
PET in Men with Newly Diagnosed High-risk Prostate Cancer and Negative Conventional Imaging Presenter: Phillip H. Departments of Medical Imaging, Medicine, and Biomedical Engineering, University of Arizona, Tucson, Ariz., Kuo, MD, Ph.D., on behalf of Gary A. Ulaner, MD, Ph.D., Hoag Family Cancer Institute, Irvine, Calif.
Diagnostic 105
105 
SNMMI Elects Jean-Luc C. Urbain, MD, PhD, FASNC, as President-Elect at 2024 Annual Meeting
Imaging Technology
JUNE 10, 2024
As SNMMI president-elect, I plan to focus on bringing and integrating radiopharmaceutical theranostics into the clinic to benefit as many patients as possible. SNMMI introduced a new slate of officers during its 2024 Annual Meeting, held June 8-11 in Toronto. “As
Martin B. Shirley Executive Vice President Sales, Marketing & Clinical Operations
TTG Imaging Solutions
AUGUST 1, 2023
Prior to this, he served in a variety of roles during his tenure at Digirad including National, Regional and Territory Sales Management positions in both the Digirad Imaging Solutions Division and the Product Division (Digirad Diagnostic Imaging, Inc). He was also a Territory Manager for DuPont Radiopharmaceuticals.
Martin B. Shirley Executive Vice President Sales, Marketing & Clinical Operations
TTG Imaging Solutions
AUGUST 1, 2023
Prior to this, he served in a variety of roles during his tenure at Digirad including National, Regional and Territory Sales Management positions in both the Digirad Imaging Solutions Division and the Product Division (Digirad Diagnostic Imaging, Inc). He was also a Territory Manager for DuPont Radiopharmaceuticals.
Additional Results of POSLUMA (Flotufolastat F 18) Performance in Newly Diagnosed, High-risk Prostate Cancer Patients Presented at ASTRO
Imaging Technology
OCTOBER 5, 2023
Kuo, MD, Ph.D. , Departments of Medical Imaging, Medicine, and Biomedical Engineering. The demonstrated performance of PSMA-PET imaging fits an important unmet need, given that conventional imaging techniques are limited in the information they provide. on behalf of Gary A.
Diagnose 52
52 
Regulatory Compliance and Approval Processes in Medical Devices
Open Medscience
JUNE 23, 2024
Medical Device Regulatory Compliance ensures safety and effectiveness through stringent testing and approval processes globally. The post Regulatory Compliance and Approval Processes in Medical Devices appeared first on Open MedScience.
How to Read a PET Scan: A Basic Understanding
Open Medscience
JULY 12, 2024
PET scans are crucial for detecting metabolic activity, providing valuable insights into cancer, neurological disorders, and cardiovascular diseases. The post How to Read a PET Scan: A Basic Understanding appeared first on Open MedScience.
PET Scan 40
40 
Breakthroughs in Positron Emission Tomography Imaging
Open Medscience
MAY 14, 2024
Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.
Imaging 40
40 
Meet the Minnies 2024 semifinal candidates
AuntMinnie
OCTOBER 2, 2024
The following is the list of candidates for the 2024 edition of the Minnies, AuntMinnie.com 's campaign to recognize the best and brightest in medical imaging. breast cancer detection software, Hologic Grace multimodal foundation model for medical imaging, HOPPR HealthFLD liver attenuation AI software, Nanox.ai
NorthStar Medical Radioisotopes Announces Supply Agreement with Nucleus RadioPharma for Alpha-emitting Therapeutic Radioisotope Actinium-225 (Ac-225)
Imaging Technology
JULY 5, 2023
Ac-225 is a high energy alpha-emitting radioisotope of increasing interest for clinical studies investigating the use of targeted radiopharmaceutical therapy, which combines select molecules with therapeutic radioisotopes to directly target and deliver therapeutic doses of radiation to destroy cancer cells in patients with serious disease.
Medical 92
92 
China limits exports of rare earth elements, targets CT x-ray tubes
AuntMinnie
APRIL 4, 2025
As part of a retaliation against new tariffs imposed by the Trump administration, China announced April 4 that it would limit export of rare earth elements, including several used in medical imaging and treatments. It also launched investigations related to imports of CT x-ray tubes.
X-ray 317
317 
Let's personalize your content